Back
Checkpoint Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
62
CKPT
Checkpoint Therapeutics
Last Price:
$4.11
Seasonality Move:
5.31%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CKPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Checkpoint Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.05 | Buy |
20-day SMA: | 4.03 | Buy |
50-day SMA: | 3.65 | Buy |
200-day SMA: | 3.1 | Buy |
8-day EMA: | 4.05 | Buy |
20-day EMA: | 3.74 | Buy |
50-day EMA: | 2.61 | Buy |
200-day EMA: | 0.92 | Buy |
Checkpoint Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.5 | Buy |
Relative Strength Index (14 RSI): | 67.99 | Buy |
Chaikin Money Flow: | 1258288 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4 - 4.06) | Buy |
Bollinger Bands (100): | (3.06 - 4.08) | Buy |
Checkpoint Therapeutics Technical Analysis
Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Checkpoint Therapeutics Stock
Is Checkpoint Therapeutics Stock a Buy?
-
Checkpoint Therapeutics share price is 4.10 while CKPT 8-day simple moving average is 4.05, which is a Buy signal.
-
The stock price of CKPT is 4.10 while Checkpoint Therapeutics 20-day SMA is 4.03, which makes it a Buy.
-
Checkpoint Therapeutics 50-day simple moving average is 3.65 while CKPT share price is 4.10, making it a Buy technically.
-
CKPT stock price is 4.10 and Checkpoint Therapeutics 200-day simple moving average is 3.10, creating a Buy signal.
CKPT Technical Analysis vs Fundamental Analysis
Buy
62
Checkpoint Therapeutics (CKPT)
is a Buy
Is Checkpoint Therapeutics a Buy or a Sell?
-
Checkpoint Therapeutics stock is rated a BuyThe current Checkpoint Therapeutics [CKPT] share price is $4.10. The Score for CKPT is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
Checkpoint Therapeutics Stock Info
Market Cap:
343.4M
Price in USD:
4.10
Share Volume:
1.3M
Checkpoint Therapeutics 52-Week Range
52-Week High:
4.50
52-Week Low:
1.38
Buy
62
Checkpoint Therapeutics (CKPT)
is a Buy
Checkpoint Therapeutics Share Price Forecast
-
What is the Checkpoint Therapeutics stock price today?The Checkpoint Therapeutics stock price is 4.10 USD today.
-
Will CKPT stock go up or go down?Checkpoint Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Checkpoint Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Checkpoint Therapeutics is not overvalued.
Is Checkpoint Therapeutics Stock a Buy?
-
Checkpoint Therapeutics share price is 4.10 while CKPT 8-day exponential moving average is 4.05, which is a Buy signal.
-
The stock price of CKPT is 4.10 while Checkpoint Therapeutics 20-day EMA is 3.74, which makes it a Buy.
-
Checkpoint Therapeutics 50-day exponential moving average is 2.61 while CKPT share price is 4.10, making it a Buy technically.
-
CKPT stock price is 4.10 and Checkpoint Therapeutics 200-day simple moving average is 0.92, creating a Buy signal.
Fundamental Analysis of Checkpoint Therapeutics
Is Checkpoint Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.13 per share, and an increase next year of $0.86 per share.
Technical Analysis of Checkpoint Therapeutics
Should I short Checkpoint Therapeutics stock?
-
CKPT Moving Average Covergence Divergence (MACD) indicator is 0.5, suggesting Checkpoint Therapeutics is a Buy
-
Checkpoint Therapeutics Relative Strength Index (RSI) is 67.99, which suggest Checkpoint Therapeutics is overbought
-
The Bollinger Bands (25) for Checkpoint Therapeutics is (4 - 4.06), which suggest Checkpoint Therapeutics is a Buy
-
The Bollinger Bands (100) for Checkpoint Therapeutics is (3.06 - 4.08), which suggest Checkpoint Therapeutics is a Buy
* Checkpoint Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.